Farnesol attenuates 1,2-dimethylhydrazine induced oxidative stress, inflammation and apoptotic responses in the colon of Wistar rats

Chemico-Biological Interactions

Volumn 192, Issue 3, 2011, Pages 193-200

  Khan, Rehan ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

1,2 Dimethylhydrazine; Apoptosis; Colon; Farnesol; Inflammation; Oxidative stress

Indexed keywords

CASPASE 3; CATALASE; FARNESOL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COLON CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; WISTAR RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CARCINOGENS; CASPASE 3; CATALASE; COLON; FARNESOL; GASTROENTERITIS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS NORVEGICUS; ZEA MAYS;

EID: 79957633659     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2011.03.009     Document Type: Article

References (84)

1. C.A. O'Brien, A. Pollett, S. Gallinger, J.E. Dick, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature 445 (2007) 106-110. (Pubitemid 46067310)
2. P.A. Janne, R.J. Mayer, Chemoprevention of colorectal cancer, N. Engl. J. Med. 342 (26) (2000) 1960-1968. (Pubitemid 30419092)
3. H. Bartsch, J. Nair, Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: studies on exocylic base adducts as stable oxidative stress marker, Cancer Detect. Prev. 26 (2002) 308-312.
4. J. Terzic, S. Grivennikov, E. Karin, M. Karin, Inflammation and colon cancer, Gastroenterology 138 (6) (2010) 2101-2114.
5. L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, S.E. Girardin, Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation, Clin. Exp. Immunol. 147 (2) (2007) 227-235. (Pubitemid 46095999)
6. P. Correa, W. Haenszel, The epidemiology of large bowel cancer, Adv. Cancer Res. 26 (1978) 1-141.
7. R. Doll, General epidemiologic considerations in etiology of colorectal cancer, in: S. Winawer, D. Schotterfield, P. Sherlock (Eds.), Colorectal Cancer: Prevention, Epidemiology, and Screening, Raven Press, New York, 1980, pp. 3-12.
8. M.J. Burstein, Dietary factors related to colorectal neoplasms, Surg. Clin. N. Am. 73 (1993) 13-29.
9. B.R. Bansal, J.E. Rhoads, S.C. Bansal, Effects of diet on colon carcinogenesis and the immune system in rats treated with 1,2-dimethylhydrazine, Cancer Res. 38 (1978) 3293-3303.
10. B.S. Reddy, T. Narisawa, J.H. Weisburger, Effect of a diet with high levels of protein and fat on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, J. Natl. Cancer Inst. 57 (1976) 567-569.
11. B.S. Reddy, K. Watanabe, J.H. Weisburger, Effect of high-fat diet on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine, methylazoxymethanolacetate, or methylnitrosourea, Cancer Res. 37 (1977) 4156-4159.
12. K. Hioki, N. Shivapurkar, H. Oshima, O. Alabaster, M. Oshima, M.M. Taketo, Suppression of intestinal polyp development by low-fat and high-fiber diet in Apcn716 knockout mice, Carcinogenesis 18 (10) (1997) 1863-1865. (Pubitemid 28132366)
13. L.W. Wattenberg, L.K.T. Lam, A.V. Fladmose, Inhibition of chemical carcinogen induced neoplasia by coumarins and a-angelicalactone, Cancer Res. 39 (1979) 1651-1654. (Pubitemid 9172689)
14. D.E. Corpet, S. Tache, Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency, Nutr. Cancer 43 (1) (2002) 1-21. (Pubitemid 35387251)
15. D.C. Crick, D.A. Andres, C.J. Waechter, Novel salvage pathway utilizing farnesol and geranylgeraniol for protein isoprenylation, Biochem. Biophys. Res. Commun. 237 (1997) 483-487. (Pubitemid 27434709)
16. T.E. Meigs, R.D. Simoni, Farnesol as a regulator of HMGCoA reductase degradation: characterization and role of farnesyl pyrophosphatase, Arch. Biochem. Biophys. 345 (1997) 1-9. (Pubitemid 27374202)
17. L. He, H. Mo, S. Hadisusilo, A.A. Qureshi, C.E. Elson, Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo, J. Nutr. 127 (1997) 668-674. (Pubitemid 27200738)
18. D. Tatman, H. Mo, Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells, Cancer Lett. 175 (2002) 129-139.
19. T.L. Horn, L. Long, M.J. Cwik, R.L. Morrissey, I.M. Kapetanovic, D.L. McCormick, Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol, Chem. Biol. Interact. 152 (2005) 79-99. (Pubitemid 40517147)
20. J. Zhao, P. Nan, Y. Zhong, Chemical composition of the essential oils of Clausena lansium from Hainan Island, China, Z. Naturforsch. C 59 (2004) 153-156. (Pubitemid 38492600)
21. T. Jahangir, T.H. Khan, L. Prasad, S. Sultana, Farnesol prevents Fe-NTA mediated renal oxidative stress and early tumour promotion markers in rats, Hum. Exp. Toxicol. 25 (2006) 235-242. (Pubitemid 43828794)
22. W. Qamar, S. Sultana, Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention, Chem. Biol. Interact. 176 (2008) 79-87.
23. P.L. Crowell, Prevention and therapy of cancer by dietary monoterpenes, J. Nutr. 129 (1999) 775S-778S.
24. J.T. Belanger, Perillyl alcohol: applications in oncology, Altern. Med. Rev. 3 (1998) 448-457. (Pubitemid 128709690)
25. P.S. Coleman, L.-C. Chen, L. Sepp-Lorenzino, Cholesterol metabolism and tumor cell proliferation, Subcell. Biochem. 28 (1997) 363-426.
26. P.A. Edwards, J. Ericsson, Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway, Annu. Rev. Biochem. 68 (1999) 157-185. (Pubitemid 29449190)
27. L. He, H. Mo, S. Hadisusilo, A.A. Qureshi, C.E. Elson, Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo, J. Nutr. 127 (1997) 668-674. (Pubitemid 27200738)
28. T.E. Meigs, D.A. Roseman, R.D. Simone, Regulation of 3-hydroxy- 3-methylglutaryl-CoA reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo, J. Biol. Chem. 71 (1996) 7916-7922.
29. Y.D. Burke, A.S. Ayoubi, S.R. Werner, B.C. McFarland, D.K. Heilman, B.A. Ruggeri, P.L. Crowell, Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention, Anticancer Res. 22 (2002) 3127-3134.
30. C.V. Rao, H.L. Newmark, B.S. Reddy, Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis, Cancer Detect. Prev. 26 (2002) 419-425.
31. D.A. Wiseman, S.R. Werner, P.L. Crowell, Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells, J. Pharmacol. Exp. Ther. 320 (2007) 1163-1170.
32. N. Khan, F. Afaq, H. Mukhtar, Apoptosis by dietary factors: the suicide solution for delaying cancer growth, Carcinogenesis 28 (2) (2007) 233-239. (Pubitemid 46321838)
33. T.M. Buttke, P.A. Sandstrom, Oxidative stress as a mediator of apoptosis, Immunol. Today 15 (1994) 7-10.
34. A.F. Slater, C.S. Nobel, S. Orrenius, The role of intracellular oxidants in apoptosis, Biochim. Biophys. Acta 1271 (1995) 59-62.
35. D.W. Heitman, B.G. Grubbs, T.O. Heitman, I.L. Cameron, Effects of 1,2-dimethylhydrazine treatment and feeding regimen on rat colonic epithelial cell proliferation, Cancer Res. 43 (1983) 1153-1162.
36. C.T. Oravec, C.A. Jones, E. Huberman, Activation of the colon carcinogen 1,2-dimethyl hydrazine in a rat colon cell-mediated mutagenesis assay, Cancer Res. 46 (1986) 5068-5071.
37. M. Sengottuvelan, P. Viswanathan, N. Nalini, Chemopreventive effect of transresveratrol - a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcinogenesis, Carcinogenesis 27 (5) (2006) 1038-1046.
38. A.V. Arutiunian, V.M. Prokopenko, S.O. Burmistrov, T.I. Oparina, E.V. Frolova, M.A. Zabezhinski, I.G. Popovich, V.N. Anisimov, Free-radical processes in blood serum, liver and large bowel during 1,2-dimethylhydrazine-induced carcinogenesis in rats, Vopr. Onkol. 43 (1997) 618-622.
39. E.S. Fiala, Investigations into the metabolism and mode of action of the colon carcinogens 1,2-dimethylhydrazine and azoxymethane, Cancer 40 (1977) 2436-2445. (Pubitemid 8237744)
40. J.W. Park, K.C. Cundy, B.N. Ames, Detection of DNA adducts by HPLC with electrochemical detection, Carcinogenesis 11 (1989) 1447-1450.
41. B. Halliwell, J.M.C. Gutteridge, Role of free radicals and catalytic metal ions in human disease: an overview, Methods Enzymol. 186 (1990) 1-85. (Pubitemid 20279941)
42. H.C. Wei, K. Frenkel, Relationship of oxidative events and DNA oxidation in SENECAR mice to in vivo promoting activity of phorbol ester-type tumor promoters, Carcinogenesis 14 (1993) 1195-1201. (Pubitemid 23193551)
43. P. Latham, E.K. Lund, I.T. Johnson, Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon, Carcinogenesis 20 (4) (1999) 645-650.
44. K.M. Pozharisski, A.J. Likhachev, V.F. Klimashevski, J.D. Shaposhnikov, Experimental intestinal cancer research with special reference to human pathology, Adv. Cancer Res. 30 (1979) 165-237.
45. A.E. Rogers, K.M. Nauss, Rodent models for carcinoma of the colon, Dig. Dis. Sci. 30 (1985) 87S-102S.
46. J.H. Weisburger, B.S. Reddy, E.L. Wynder, Colon cancer: its epidemiology and experimental production, Cancer 40 (1977) 2414-2420. (Pubitemid 8237740)
47. D.J. Jollow, J.R. Mitchell, N. Zampaglione, J.R. Gillette, Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite, Pharmacology 11 (1974) 151-169.
48. M. Mohandas, J.J. Marshall, G.G. Duggin, J.S. Horvath, D. Tiller, Differential distribution of glutathione and glutathione related enzymes in rabbit kidney, Cancer Res. 44 (1984) 5086-5091.
49. I. Carlberg, B. Mannervik, Glutathione level in rat brain, J. Biol. Chem. 250 (1975) 5475-5480.
50. W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (1974) 7130-7139.
51. S. Marklund, G. Marklund, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase, Eur. J. Biochem. 47 (1974) 469-474.
52. A. Claiborne, Catalase activity, in: R.A. Greenwald (Ed.), CRC Handbook of Methods in Oxygen Radical Research, CRC, Boca Raton, RA, 1985, pp. 283-284.
53. 2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimuli, Cell Immunol. 59 (1981) 301-308.
54. A.M. Benson, M.J. Hunkeler, P. Talalay, Increase of NAD(P)H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity, Proc. Natl. Acad. Sci. USA 77 (1980) 5216-5220. (Pubitemid 11195538)
55. J.R. Wright, H.D. Colby, P.R. Miles, Cytosolic factors which affect microsomal lipid peroxidation in lung and liver, Arch. Biochem. Biophys. 206 (1981) 296-304. (Pubitemid 11102033)
56. O.H. Lowry, N.J. Rosebrough, A. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
57. K.A. Steinmetz, J.D. Potter, Vegetables, fruit and cancer. I. Epidemiology, Cancer Causes Control 2 (5) (1991) 325-357.
58. L.W. Wattenberg, Chemoprevention of cancer, Prev. Med. 25 (1996) 44-45.
59. T.P. Ong, R. Heidor, A. de Conti, M.L. Dagli, F.S. Moreno, Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase, Carcinogenesis 27 (2006) 1194-1203.
60. B.C. Pence, Dietary selenium and antioxidant status: toxic effects of 1,2-dimethylhydrazine in rats, J. Nutr. 121 (1991) 138-144.
61. S. Kawanishi, K. Yamamoto, Mechanism of site-specific DNA damage induced by methylhydrazines in the presence of copper (II) or manganese (III), Biochemistry 30 (1991) 3069-3075.
62. P.K. Dudeja, T.A. Brasitus, 1,2-Dimethylhydrazine-induced alterations in lipid peroxidation in preneoplastic and neoplastic colonic tissues, Biochim. Biophys. Acta 1046 (1990) 267-270.
63. A. Seven, S. Civelek, E. Inci, N. Korkut, G. Burcak, Evaluation of oxidative stress parameters in blood of patients with laryngeal carcinoma, Clin. Biochem. 32 (1999) 369-373.
64. F.H. Mukai, B.D. Goldstein, Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids, Science 191 (1976) 868-869.
65. T.M. Yau, Mutagenicity and cytotoxicity of malonaldehyde in mammalian cells, Mech. Ageing Dev. 11 (1979) 137-144.
66. H.J. Forman, H. Zhang, A. Rinna, Glutathione: overview of its protective roles, measurement, and biosynthesis, Mol. Aspects Med. 30 (1-2) (2009) 1-12.
67. S. Sharma, S. Sultana, Modulatory effect of soy isoflavones on biochemical alterations mediated by TPA in mouse skin model, Food Chem. Toxicol. 42 (2004) 1669-1675.
68. K.T. Douglas, Mechanism of action of glutathione-dependent enzymes, Adv. Enzymol. Relat. Areas Mol. Biol. 59 (1987) 103-167.
69. N.V. Rajeshkumar, R. Kuttan, Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by picroliv, Cancer Lett. 191 (2003) 137-143.
70. D. Dreher, A.F. Junod, Role of oxygen free radicals in cancer development, Eur. J. Cancer 32 (1996) 30-38.
71. T.L. Horn, L. Long, M.J. Cwik, R.L. Morrissey, I.M. Kapetanovic, D.L. McCormick, Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol, Chem. Biol. Interact. 152 (2005) 79-99. (Pubitemid 40517147)
72. J.H. Joo, A.M. Jetten, Molecular mechanisms involved in farnesol-induced apoptosis, Cancer Lett. 287 (2010) 123-135.
73. S.C. Chaudhary, M.S. Alam, M.S. Siddiqui, M. Athar, Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis, Life Sci. 85 (2009) 196-205.
74. V.D. Chadha, K. Vaiphei, D.K. Dhawan, Zinc mediated normalization of histoarchitecture and antioxidant status offers protection against initiation of experimental carcinogenesis, Mol. Cell Biochem. 304 (2007) 101-108.
75. K. Stone, E. Bermudez, W.A. Pryor, Aqueous extracts of cigarette tar containing the tar free radical cause DNA nicks in mammalian cells, Environ. Health Perspect. 102 (1994) 173-178.
76. K.J. Rogers, A.E. Pegg, Formation of O6-methyl guanine by alkylation of rat liver colon and kidney DNA following administration of 1,2-dimethyhydrazine, Cancer Res. 37 (1977) 4082-4087.
77. D.P. Lane, Cancer. P53, guardian of the genome, Nature 358 (1992) 15-16.
78. E. Goncu, O. Parlak, Some autophagic and apoptotic features of programmed cell death in the anterior silk glands of the silkworm, Bombyx mori, Autophagy 4 (8) (2008) 1069-1072.
79. S. Ghavami, M. Hashemi, S.R. Ande, Apoptosis and cancer: mutations within caspase genes, J. Med. Genet. 46 (2009) 497-510.
80. J. Wen, K.R. You, S.Y. Lee, C.H. Song, D.G. Kim, Oxidative stress-mediated apoptosis: the anticancer effect of the sesquiterpene lactone parthenolide, J. Biol. Chem. 277 (2002) 38954-38964.
81. G.M. Cohen, Caspases: the executioners of apoptosis, Biochem. J. 326 (1997) 1-16. (Pubitemid 27386911)
82. A. Marcuzzi, A. Pontillo, L. De Leo, A. Tommasini, G. Decorti, T. Not, A. Ventura, Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency, Pediatr. Res. 64 (2) (2008) 177-182.
83. S.C. Chaudhary, M.S. Alam, M.S. Siddiqui, M. Athar, Chemopreventive effect of farnesol on DMBA/TPA-induced skin tumorigenesis: involvement of inflammation, Ras-ERK pathway and apoptosis, Life Sci. 85 (5-6) (2009) 196-205.
84. H.M.L.P.N. Navarathna Dhammika, W.N. Kenneth, E.D. Gerald, R.J. Thomas, M.P. Thomas, Exogenous farnesol interferes with the normal progression of cytokine expression during candidiasis in a mouse model, Infect. Immun. 75 (2007) 4001-4006.